Investigating the Role of Novel Fatty Acid-Binding Protein (FABP) Inhibitors as Treatments for Anxiety Disorders

Anxiety disorders and chronic stress represent major healthcare and economic burdens worldwide. Approximately 75% of Canadians who use health services for a mental illness present with anxiety disorders which may affect up to 10% of the population in terms of lifetime occurrence. Despite the large prevalence of anxiety-related disorders in Canada, there are currently a […]

Read More